DEL-AI Platform: A Cutting-Edge Innovation Engine
Nurix's DEL-AI drug discovery engine is a game-changer in the industry, harnessing the power of DNA Encoded Libraries (DEL), ligase binders, automated chemistry, direct to biology capabilities, and machine learning. This sophisticated platform enables the development of novel drugs simultaneously targeting a wide array of proteins, showcasing Nurix's commitment to innovation and discovery.
Targeted Protein Degradation: A Paradigm Shift in Treatment Strategy
Nurix believes in the future of medicine through targeted protein degradation (TPD), a revolutionary approach that utilizes the cell's natural protein disposal system to eliminate disease-causing proteins. By focusing on degraders and degrader antibody conjugates, Nurix is paving the way for new modalities that have the potential to address historically challenging diseases, offering hope for improved treatment outcomes.
Resource Library: A Treasury of Scientific Advancements
Nurix's resource library is a goldmine of scientific publications, presentations, and educational materials that highlight the organization's groundbreaking research in protein degradation. With a commitment to advancing the field and delivering degrader-based medicines to patients globally, Nurix's scientific repository serves as a testament to its dedication to scientific excellence and innovation.
Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive
seamless operations, and scale effortlessly for long-term success.
Book a Meeting to Avail the Services of Nurix